FDA Classifies Medtronic Harmony Recall as Class I

• by Kathryn Wighton

• July 15, 2026

Prognostic significance of pan-immune-inflammatory value in adverse cardiovascular and cerebrovascular events post-percutaneous coronary intervention in diabetic patients with coronary heart disease

• by Qinghong Liu, Mao Tian, Jiangjun Guo, Wenhao Chen, Wenting Wu, Huadong Yu, Bo Zhu

• July 7, 2026

Quality improvement: prevention of cardiac arrest in children with heart disease on the paediatric intensive care unit

• by Mark James Russell, Alison Jones, Susan Burlton, Rachael Morrison, David Ellis, Tim Jones, Natasha Khan, Hari Krishnan, Phil Botha

• July 14, 2026

Can Sugammadex Lower Postsurgical Pulmonary Complications?

A large international randomized trial found fewer postoperative pulmonary complications with sugammadex vs. neostigmine following major abdominal or thoracic surgery, although the difference was driven primarily by reduced atelectasis.

• by Andrea Surnit

• July 17, 2026

• 3 min